Amicus Therapeutics (FOLD) Revenue (2010 - 2025)
Amicus Therapeutics (FOLD) revenue from Jun 30, 2010 to Dec 31, 2025. The TTM Amicus Therapeutics (FOLD) revenue is $634M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Amicus Therapeutics (FOLD) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +20.05% |
| 3 Years TTM | +24.42% |
| 5 Years TTM | +19.44% |
| All Time TTM | +33.11% |
Annual Revenue change of Amicus Therapeutics (FOLD)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $634M | +20.05% |
| 2024 | $528M | +32.28% |
| 2023 | $399M | +21.30% |
| 2022 | $329M | +7.76% |
| 2021 | $306M | +17.10% |
| 2020 | $261M | +43.16% |
| 2019 | $182M | +99.72% |
| 2018 | $91M | +147.09% |
| 2017 | $37M | +644.56% |
| 2016 | $4.96M | N/A |
| 2015 | $0 | -100.00% |
| 2014 | $1.22M | +238.89% |
| 2013 | $360K | -98.04% |
| 2012 | $18M | -14.09% |
| 2011 | $21M | +2229.35% |
| 2010 | $920K | -98.57% |
| 2009 | $64M | N/A |
| 2008 | $0 | N/A |
| 2007 | $0 | N/A |
| 2006 | $0 | N/A |
| 2005 | $0 | N/A |
| 2004 | $0 | N/A |
| 2003 | $0 | N/A |
| 2002 | $0 | N/A |
Comparison Amicus Therapeutics (FOLD) five years revenue CAGR with competitors
Amicus Therapeutics (FOLD) five years revenue CAGR is 19.44%.